You are on page 1of 3

DRUG MECHANISM OF INDICATION CONTAINDICATION SIDE EFFECT ADVERSE NURSING

ACTION EFFECT CONSIDERATION

DRUG DOCTOR’S MECHANISM OF INDICATIONS CONTAINDICATIONS SIDE EFFECT ADVERSE NURSING


ORDER ACTION EFFECT CONSIDERATION
GENERIC NAME: DOSAGE:

BRAND NAME: FREQUENCY:

THERAPEUTIC ROUTE:
CLASS:

PHARMACOLOGIC
CLASS:

NAME: SARMIENTO, BERVY ALA M. YEAR/SECTION/GROUP NO.: BSN2 F4 CLINICAL INSTRUCTOR: MA’AM MARY ROSE C. JONTILANO
DRUG MECHANISM OF INDICATION CONTAINDICATION SIDE EFFECT ADVERSE NURSING
ACTION EFFECT CONSIDERATION

DRUG NAME:

GENERIC NAME:

BRAND NAME:

CLASSIFICATION:

You might also like